Legacy Financial Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-132
Closed -$19K 1028
2019
Q1
$19K Buy
132
+44
+50% +$6.38K 0.01% 468
2018
Q4
$12K Buy
88
+50
+132% +$8.2K ﹤0.01% 528
2018
Q3
$7K Sell
38
-55
-59% -$10.1K ﹤0.01% 629
2018
Q2
$16K Buy
93
+82
+745% +$13.2K 0.01% 422
2018
Q1
$1K Sell
11
-834
-99% -$140K ﹤0.01% 801
2017
Q4
$138K Buy
+845
New +$152K 0.06% 147

Other funds holding AGN

Legacy Financial Advisors's AGN Position: Q2 2019 in Review

Legacy Financial Advisors sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 132 shares — an estimated $19K sold.

Legacy Financial Advisors first reported a position in AGN in Q4 2017 and held it in 6 quarters. The position peaked at $138K in Q4 2017. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Legacy Financial Advisors reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Legacy Financial Advisors sold 132 Allergan plc shares in Q2 2019, an estimated $19K.
  • Legacy Financial Advisors first reported a position in Allergan plc in Q4 2017 and held it in 6 quarters.
  • Legacy Financial Advisors's Allergan plc position peaked at $138K in Q4 2017.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Legacy Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.